Page last updated: 2024-08-26

sr141716 and Recrudescence

sr141716 has been researched along with Recrudescence in 11 studies

Research

Studies (11)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (45.45)29.6817
2010's6 (54.55)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Eiler, WJA; Gleason, SD; Smith, JL; Witkin, JM1
Cruz, JS; De Carvalho, CR; Pamplona, FA; Takahashi, RN1
Jing, L; Li, JX; Qiu, Y; Zhang, Y1
Bergman, J; Goldberg, SR; Justinova, Z; Le Foll, B; Makriyannis, A; Redhi, GH; Schindler, CW; Vemuri, K1
Fang, Q; Li, D; Li, F; Liu, Y; Lu, L; Wang, J; Zhao, M1
Dykstra, LA; Rosenberg, M; Walker, EA; Ward, SJ1
Bartels, M; Kis, B; Scherbaum, N; Ugur, T1
Dudek, FE; Pouliot, WA; Rossi, CA; Staley, KJ1
Boustany-Kari, CM; Gibbons, CP; Jackson, VM; Swick, AG1
Cabras, C; Carai, MA; Colombo, G; Gessa, GL; Lai, P; Maccioni, P; Orrù, A; Rubio, M1
Crombag, H; De Vries, TJ; Dieben, J; Homberg, JR; Schoffelmeer, AN; Schuurman, K; Shaham, Y; Vanderschuren, LJ1

Reviews

1 review(s) available for sr141716 and Recrudescence

ArticleYear
The cannabinoid CB1 receptor antagonist, rimonabant, as a promising pharmacotherapy for alcohol dependence: preclinical evidence.
    Molecular neurobiology, 2007, Volume: 36, Issue:1

    Topics: Alcohol Drinking; Alcoholism; Animals; Humans; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Opioid; Recurrence; Rimonabant

2007

Other Studies

10 other study(ies) available for sr141716 and Recrudescence

ArticleYear
A medium throughput rodent model of relapse from addiction with behavioral and pharmacological specificity.
    Pharmacology, biochemistry, and behavior, 2019, Volume: 183

    Topics: Amino Acids; Animals; Behavior, Addictive; Behavior, Animal; Bridged Bicyclo Compounds, Heterocyclic; Cannabinoid Receptor Antagonists; Conditioning, Operant; Drug Discovery; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Extinction, Psychological; Feeding Behavior; Male; Models, Animal; Pyridines; Rats; Rats, Sprague-Dawley; Recurrence; Rimonabant; Self Administration; Substance-Related Disorders; Thiazoles

2019
Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats.
    Psychopharmacology, 2014, Volume: 231, Issue:7

    Topics: Amidohydrolases; Animals; Benzamides; Benzoxazines; Carbamates; Conditioning, Psychological; Cues; Endocannabinoids; Indoles; Male; Memory; Morphine; Morpholines; Naphthalenes; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Recurrence; Rimonabant; Secondary Prevention

2014
Effects of the cannabinoid CB₁ receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats.
    Drug and alcohol dependence, 2014, Oct-01, Volume: 143

    Topics: Allosteric Regulation; Amphetamine-Related Disorders; Animals; Cocaine-Related Disorders; Cues; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Indoles; Male; Methamphetamine; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Recurrence; Rimonabant; Self Administration

2014
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016, Volume: 41, Issue:9

    Topics: Animals; Conditioning, Operant; Cues; Dronabinol; Drug-Seeking Behavior; Male; Marijuana Abuse; Nicotine; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Recurrence; Reinforcement, Psychology; Rimonabant; Saimiri; Self Administration; Tobacco Use Disorder

2016
Cannabinoid CB(1) receptor antagonist rimonabant attenuates reinstatement of ketamine conditioned place preference in rats.
    European journal of pharmacology, 2008, Jul-28, Volume: 589, Issue:1-3

    Topics: Animals; Behavior, Animal; Conditioning, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Extinction, Psychological; Injections, Intraperitoneal; Ketamine; Male; Piperidines; Psychotropic Drugs; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Recurrence; Rimonabant; Substance-Related Disorders

2008
The CB1 antagonist rimonabant (SR141716) blocks cue-induced reinstatement of cocaine seeking and other context and extinction phenomena predictive of relapse.
    Drug and alcohol dependence, 2009, Dec-01, Volume: 105, Issue:3

    Topics: Animals; Behavior, Addictive; Cocaine; Cocaine-Related Disorders; Conditioning, Operant; Corn Oil; Cues; Dietary Sucrose; Disease Models, Animal; Extinction, Psychological; Food, Formulated; Male; Mice; Mice, Inbred C57BL; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Recurrence; Reinforcement Schedule; Rimonabant; Self Administration; Water

2009
Psychosis following anti-obesity treatment with rimonabant.
    Obesity facts, 2008, Volume: 1, Issue:2

    Topics: Adult; Anti-Obesity Agents; Chronic Disease; Female; Humans; Obesity; Piperidines; Pyrazoles; Recurrence; Rimonabant; Schizophrenia, Paranoid

2008
The effect of the cannabinoid-receptor antagonist, SR141716, on the early stage of kainate-induced epileptogenesis in the adult rat.
    Epilepsia, 2010, Volume: 51 Suppl 3

    Topics: Age Factors; Animals; Brain; Cannabinoid Receptor Antagonists; Convulsants; Disease Models, Animal; Electroencephalography; Epilepsy; Kainic Acid; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Recurrence; Rimonabant; Status Epilepticus

2010
Leptin potentiates the anti-obesity effects of rimonabant.
    European journal of pharmacology, 2011, May-11, Volume: 658, Issue:2-3

    Topics: Animals; Anti-Obesity Agents; Dose-Response Relationship, Drug; Drug Synergism; Leptin; Male; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Recurrence; Rimonabant; Ventromedial Hypothalamic Nucleus; Weight Loss

2011
A cannabinoid mechanism in relapse to cocaine seeking.
    Nature medicine, 2001, Volume: 7, Issue:10

    Topics: Animals; Behavior, Animal; Cannabinoid Receptor Modulators; Cannabinoids; Cocaine; Cocaine-Related Disorders; Disease Models, Animal; Dronabinol; Humans; Piperidines; Pyrazoles; Rats; Rats, Long-Evans; Rats, Wistar; Receptors, Cannabinoid; Receptors, Drug; Recurrence; Rimonabant

2001